| Sep 25 |
Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024
|
| Sep 20 |
Tarsus Pharmaceuticals: Unlocking Growth Potential With Eye Care Innovations
|
| Aug 28 |
Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference
|
| Aug 20 |
Tarsus Pharmaceuticals: Strong Execution In Eye Disease Treatment
|
| Aug 11 |
Need To Know: Analysts Are Much More Bullish On Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Revenues
|
| Aug 10 |
Tarsus Pharmaceuticals, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 10 |
Tarsus Pharmaceuticals, Inc. (TARS) Q2 2024 Earnings Call Transcript
|
| Aug 9 |
Tarsus Pharmaceuticals GAAP EPS of -$0.88 beats by $0.08, revenue of $40.81M beats by $8.76M
|
| Aug 8 |
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 8 |
Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
|
